Thomas Civik - 08 Jun 2023 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
Director
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
08 Jun 2023
Transactions value $
$0
Form type
4
Filing time
12 Jun 2023, 16:22:07 UTC
Previous filing
28 Mar 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Stock Option (right to buy) Award $0 +27.2K $0.00 27.2K 08 Jun 2023 Common Shares 27.2K $11.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date.